V M Garsky

3.0k total citations · 1 hit paper
37 papers, 2.5k citations indexed

About

V M Garsky is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, V M Garsky has authored 37 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 10 papers in Oncology and 9 papers in Epidemiology. Recurrent topics in V M Garsky's work include Chemical Synthesis and Analysis (6 papers), Glycosylation and Glycoproteins Research (5 papers) and RNA and protein synthesis mechanisms (5 papers). V M Garsky is often cited by papers focused on Chemical Synthesis and Analysis (6 papers), Glycosylation and Glycoproteins Research (5 papers) and RNA and protein synthesis mechanisms (5 papers). V M Garsky collaborates with scholars based in United States, Canada and France. V M Garsky's co-authors include Paul A. Friedman, R J Gould, W. Wayt Gibbs, Masayuki Ohara, Michael D. Schaber, Mark S. Marshall, Sheri L. Moores, Richard J. Colonno, D. L. Pompliano and Elaine Rands and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

V M Garsky

37 papers receiving 2.4k citations

Hit Papers

Sequence dependence of protein isoprenylation 1991 2026 2002 2014 1991 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V M Garsky United States 23 1.7k 546 349 305 277 37 2.5k
S P Adams United States 26 2.0k 1.2× 348 0.6× 305 0.9× 145 0.5× 233 0.8× 37 3.5k
C. Chandra Kumar United States 24 1.8k 1.1× 449 0.8× 456 1.3× 144 0.5× 214 0.8× 43 2.5k
G C Dubois United States 24 2.1k 1.3× 862 1.6× 112 0.3× 177 0.6× 413 1.5× 47 3.7k
Horst Ahorn Austria 26 1.6k 1.0× 240 0.4× 522 1.5× 211 0.7× 113 0.4× 37 2.5k
Kirston Koths United States 21 2.0k 1.2× 634 1.2× 143 0.4× 238 0.8× 220 0.8× 31 3.4k
Reinout Raijmakers Netherlands 32 3.0k 1.8× 396 0.7× 205 0.6× 233 0.8× 177 0.6× 57 4.3k
Bruno Catimel Australia 26 1.5k 0.9× 488 0.9× 139 0.4× 397 1.3× 126 0.5× 73 2.3k
Kyung Johanson United States 26 1.9k 1.1× 685 1.3× 163 0.5× 128 0.4× 493 1.8× 44 2.8k
Kevin Blackburn United States 27 2.0k 1.2× 412 0.8× 226 0.6× 143 0.5× 451 1.6× 50 3.2k
Yu‐Ching E. Pan United States 19 1.3k 0.8× 326 0.6× 189 0.5× 439 1.4× 163 0.6× 32 2.8k

Countries citing papers authored by V M Garsky

Since Specialization
Citations

This map shows the geographic impact of V M Garsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V M Garsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V M Garsky more than expected).

Fields of papers citing papers by V M Garsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V M Garsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V M Garsky. The network helps show where V M Garsky may publish in the future.

Co-authorship network of co-authors of V M Garsky

This figure shows the co-authorship network connecting the top 25 collaborators of V M Garsky. A scholar is included among the top collaborators of V M Garsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V M Garsky. V M Garsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Bogusky, Michael J., Steven M. Pitzenberger, V M Garsky, et al.. (1999). Conformation of a novel tetrapeptide inhibitor NH2d‐Trp‐d‐Met‐Phe(pCl)‐Gla‐NH2bound to farnesyl‐protein transferase. Journal of Peptide Research. 54(1). 66–73. 7 indexed citations
3.
Chen, Yuan, et al.. (1994). Three-dimensional structure of echistatin and dynamics of the active site. Journal of Biomolecular NMR. 4(3). 307–24. 19 indexed citations
4.
Bock, Mark G., Robert M. DiPardo, B. Evans, et al.. (1994). ChemInform Abstract: Development of 1,4‐Benzodiazepine Cholecystokinin Type B Antagonists.. ChemInform. 25(26). 3 indexed citations
5.
Fisher, John, Malcolm P. Caulfield, Masahiko Sato, et al.. (1993). Inhibition of osteoclastic bone resorption in vivo by echistatin, an "arginyl-glycyl-aspartyl" (RGD)-containing protein.. Endocrinology. 132(3). 1411–1413. 114 indexed citations
6.
Bock, Mark G., Robert M. DiPardo, B. Evans, et al.. (1993). Development of 1,4-benzodiazepine cholecystokinin type B antagonists. Journal of Medicinal Chemistry. 36(26). 4276–4292. 51 indexed citations
7.
Huang, Pearl S., Denis R. Patrick, George M. Edwards, et al.. (1993). Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein.. Molecular and Cellular Biology. 13(2). 953–960. 106 indexed citations
8.
Stirdivant, Steven M., Hans E. Huber, Denis R. Patrick, et al.. (1992). Human papillomavirus type 16 E7 protein inhibits DNA binding by the retinoblastoma gene product.. Molecular and Cellular Biology. 12(5). 1905–1914. 31 indexed citations
10.
Moores, Sheri L., Michael D. Schaber, Elaine Rands, et al.. (1991). Sequence dependence of protein isoprenylation. Journal of Biological Chemistry. 266(22). 14603–14610. 503 indexed citations breakdown →
11.
Freidinger, Roger, Paul Williams, Roger D. Tung, et al.. (1990). Cyclic hexapeptide oxytocin antagonists. Potency-, selectivity-, and solubility-enhancing modifications. Journal of Medicinal Chemistry. 33(7). 1843–1845. 15 indexed citations
12.
Jones, Raymond E., Ronald Wegrzyn, Denis R. Patrick, et al.. (1990). Identification of HPV-16 E7 peptides that are potent antagonists of E7 binding to the retinoblastoma suppressor protein.. Journal of Biological Chemistry. 265(22). 12782–12785. 73 indexed citations
13.
Taub, Rebecca, R J Gould, V M Garsky, et al.. (1989). A monoclonal antibody against the platelet fibrinogen receptor contains a sequence that mimics a receptor recognition domain in fibrinogen. Journal of Biological Chemistry. 264(1). 259–265. 180 indexed citations
14.
McClements, W.L., Gregory Yamanaka, V M Garsky, et al.. (1988). Oligopeptides inhibit the ribonucleotide reductase of herpes simplex virus by causing subunit separation. Virology. 162(1). 270–273. 60 indexed citations
15.
Heimbrook, David, et al.. (1988). Minimal ligand analysis of gastrin releasing peptide. Receptor binding and mitogenesis.. Journal of Biological Chemistry. 263(15). 7016–7019. 36 indexed citations
16.
Socher, Susan H., Mark W. Riemen, D. Martínez, et al.. (1987). Antibodies against amino acids 1-15 of tumor necrosis factor block its binding to cell-surface receptor.. Proceedings of the National Academy of Sciences. 84(24). 8829–8833. 35 indexed citations
17.
Lien, Eric L. & V M Garsky. (1981). Route of Administration as a Determining Factor in the Selectivity of Hormone Suppression of a Somatostatin Analog in Rats. Hormone and Metabolic Research. 13(12). 675–678. 3 indexed citations
18.
Garsky, V M, et al.. (1980). Assignment of the 270 MHz nuclear magnetic resonance spectrum of somatostatin in water. Biochemical and Biophysical Research Communications. 93(2). 376–384. 21 indexed citations
19.
Lien, Eric L. & V M Garsky. (1978). Prolonged Suppression of Insulin Release by a Somatostatin Analog. Endocrinology. 103(1). 81–85. 7 indexed citations
20.
Garsky, V M, Donald E. Clark, & Norman H. Grant. (1976). Synthesis of a nonreducible cyclic analog of somatostatin having only growth hormone release inhibiting activity. Biochemical and Biophysical Research Communications. 73(4). 911–916. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026